Masafumi Kawanishi Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

9/2007

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masafumi Kawanishi Research Topics

Disease

5	Rheumatoid Arthritis 10/2023 - 11/2022
1	Body Weight (Weight, Body) 11/2023
1	Inflammation (Inflammations) 01/2023
1	Asthma (Bronchial Asthma) 09/2009
1	Respiratory Hypersensitivity 09/2009
1	Peripheral Arterial Disease 09/2007
1	Intermittent Claudication 09/2007

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 11/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 11/2022
2	4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA 09/2009 - 09/2007
1	Therapeutic UsesIBA 08/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	OvalbuminIBA 09/2009
1	Phosphodiesterase InhibitorsIBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2007
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2007

Therapy/Procedure

2	Therapeutics 08/2023 - 11/2022